Abstract
Comments1 January 1974Isoniazid HepatitisTHEODORE L. BADGER, M.D.THEODORE L. BADGER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-80-1-113 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Excerpt. . . Maddrey and Boitnott's paper, "Isoniazid Hepatitis," in the July issue . . . does not prove or, at least, not make clear, that in Baltimore, where there is a high incidence of hepatitis, other factors did not play a part in the high mortality in their cases. This latter should be made very clear by further investigation of their associated health problems, if any.Isoniazid is an extraordinarily valuable adjunct for our national program on the prevention and eradication of tuberculosis. Although its dangers should be documented, false association should not be assumed.... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByIsoniazidIVAL L. SALYER, M.D., MICHAEL H. CYNAMON, M.D.Stop Isoniazid ProphylaxisHAROLD L. ISRAEL, M.D., F.A.C.P. 1 January 1974Volume 80, Issue 1Page: 113-114KeywordsHepatitisHepatitis AIsoniazidMortality Issue Published: 1 January 1974 PDF DownloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
